Form 8-K - Current report:
SEC Accession No. 0000950170-24-127568
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:09
Documents
12
Period of Report
2024-11-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bior-20241113.htm   iXBRL 8-K 85440
2 EX-10.1 bior-ex10_1.htm EX-10.1 249374
  Complete submission text file 0000950170-24-127568.txt   500872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20241113.xsd EX-101.SCH 31517
14 EXTRACTED XBRL INSTANCE DOCUMENT bior-20241113_htm.xml XML 4898
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241467784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)